Osaic Holdings’s Cue Health Inc. Common Stock HLTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,642
| Closed | -$26 | – | 7677 |
|
|
2024
Q2 | $26 | Buy |
2,642
+471
| +22% | +$61 | ﹤0.01% | 7328 |
|
|
2024
Q1 | $412 | Buy |
2,171
+1,500
| +224% | +$341 | ﹤0.01% | 6855 |
|
|
2023
Q4 | $109 | Hold |
671
| – | – | ﹤0.01% | 7104 |
|
|
2023
Q3 | $297 | Sell |
671
-1,000
| -60% | -$456 | ﹤0.01% | 7085 |
|
|
2023
Q2 | $617 | Sell |
1,671
-988
| -37% | -$843 | ﹤0.01% | 7000 |
|
|
2023
Q1 | $4.84K | Hold |
2,659
| – | – | ﹤0.01% | 6330 |
|
|
2022
Q4 | $5K | Sell |
2,659
-7,360
| -73% | -$23.3K | ﹤0.01% | 6326 |
|
|
2022
Q3 | $30K | Hold |
10,019
| – | – | ﹤0.01% | 5306 |
|
|
2022
Q2 | $32K | Buy |
10,019
+9,519
| +1,904% | +$51.6K | ﹤0.01% | 5301 |
|
|
2022
Q1 | $3K | Sell |
500
-15,900
| -97% | -$144K | ﹤0.01% | 6801 |
|
|
2021
Q4 | $220K | Buy |
16,400
+16,100
| +5,367% | +$177K | ﹤0.01% | 3854 |
|
|
2021
Q3 | $4K | Buy |
+300
| New | +$4.73K | ﹤0.01% | 6671 |
|
Osaic Holdings's HLTH Position: Q3 2024 in Review
Osaic Holdings sold out of Cue Health Inc. Common Stock (HLTH) in Q3 2024, closing a stake of 2,642 shares — an estimated $26 sold.
Osaic Holdings first reported a position in HLTH in Q3 2021 and held it in 12 quarters. The position peaked at $220K in Q4 2021. 2 funds tracked by Wall St. Rank hold HLTH as of Q3 2024.
- Osaic Holdings reported no remaining Cue Health Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- Osaic Holdings sold 2,642 Cue Health Inc. Common Stock shares in Q3 2024, an estimated $26.
- Osaic Holdings first reported a position in Cue Health Inc. Common Stock in Q3 2021 and held it in 12 quarters.
- Osaic Holdings's Cue Health Inc. Common Stock position peaked at $220K in Q4 2021.
- 2 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q3 2024.
Based on Osaic Holdings's 13F filing for Q3 2024, filed 13 Nov 2024.